Login Register Cart 0
Generic placeholder image

当代阿耳茨海默病研究

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in English
Case Report

具有路易体病共同病理学的功能障碍性阿尔茨海默病

卷 19, 期 4, 2022

发表于: 30 March, 2022

页: [330 - 333] 页: 4

弟呕挨: 10.2174/1567205019666220308152219

价格: $65

conference banner
摘要

背景：阿尔茨海默病可以不典型地表现为进行性执行障碍综合征 (dAD)，这种疾病优先影响年轻人并且经常被误诊，这凸显了进一步研究的必要性。 目的：本研究的目的是描述两例年轻发病的 dAD 的临床、生前神经影像学和死后神经病理学特征，他们在尸检时显示出路易体病 (LBD) 共同病理学的证据。 方法：回顾每位患者的临床病史、生前 MRI 和 PET 成像以及死后神经病理学数据。案例介绍：在这两个案例中都观察到了 dAD 的典型特征，包括与工作记忆和认知灵活性相关的任务的进行性和主要损害，缺乏主要的行为/个性变化，以及生前淀粉样蛋白和 tau 异常淀粉样蛋白和 tau 沉积的证据PET和死后神经病理学。在这两个个体中都观察到海马受累相对较少，这与许多临床非典型 AD 病例一致。其中一名患者在去世前几年出现了轻微的帕金森症状以及偏执和易怒。在这两种情况下，尸检时都观察到过渡性（脑干和边缘）LBD共病理学。 结果和讨论：虽然 LBD 共病理在 AD 中并不少见，但在这些年轻发病的 dAD 病例（包括具有明显症状相关性的病例）中存在 LBD 病理，需要进一步调查更广泛的频率和潜在的病理生理学。 结论：更好地了解哪些特定的年轻发病 AD 表型与 LBD 共病理学相关，将对咨询、治疗、临床试验登记和疾病机制知识具有重要意义。

关键词: 阿尔茨海默病、非典型 AD、路易体病、病例报告、神经病理学、MRI、PET。

« Previous
[1]
Townley RA, Graff-Radford J, Mantyh WG, et al. Progressive dysexecutive syndrome due to Alzheimer's disease: A description of 55 cases and comparison to other phenotypes. Brain Commun 2020; 2: fcaa068.
[http://dx.doi.org/10.1093/braincomms/fcaa068]
[2]
Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol 2021; 20(3): 222-34.
[http://dx.doi.org/10.1016/S1474-4422(20)30440-3] [PMID: 33609479]
[3]
Kokmen E, Naessens JM, Offord KP. A short test of mental status: Description and preliminary results. Mayo Clin Proc 1987; 62(4): 281-8.
[http://dx.doi.org/10.1016/S0025-6196(12)61905-3] [PMID: 3561043]
[4]
Montine TJ, Phelps CH, Beach TG, et al. National institute on Aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol 2012; 123(1): 1-11.
[http://dx.doi.org/10.1007/s00401-011-0910-3] [PMID: 22101365]
[5]
Jones DT, Graff-Radford J. Executive dysfunction and the prefrontal cortex. Continuum (Minneap Minn) 2021; 27(6): 1586-601.
[http://dx.doi.org/10.1212/CON.0000000000001009] [PMID: 34881727]
[6]
Graff-Radford J, Murray ME, Lowe VJ, et al. Dementia with Lewy bodies: Basis of cingulate island sign. Neurology 2014; 83(9): 801-9.
[http://dx.doi.org/10.1212/WNL.0000000000000734] [PMID: 25056580]
[7]
Nedelska Z, Kantarci K. Reply to letter: Basis of cingulate island sign may differ in dementia with lewy bodies and posterior cortical atrophy. Mov Disord 2019; 34(5): 761-2.
[http://dx.doi.org/10.1002/mds.27677] [PMID: 31091363]
[8]
Robinson JL, Lee EB, Xie SX, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 2018; 141(7): 2181-93.
[http://dx.doi.org/10.1093/brain/awy146] [PMID: 29878075]
[9]
Beach TG, Malek-Ahmadi M. Alzheimer’s Disease neuropathological comorbidities are common in the younger-old. J Alzheimers Dis 2021; 79(1): 389-400.
[http://dx.doi.org/10.3233/JAD-201213] [PMID: 33285640]
[10]
Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC. Clinical features of Alzheimer Disease with and without lewy bodies. JAMA Neurol 2015; 72(7): 789-96.
[http://dx.doi.org/10.1001/jamaneurol.2015.0606] [PMID: 25985321]
[11]
Cairns NJ, Perrin RJ, Franklin EE, et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 2015; 35(4): 390-400.
[http://dx.doi.org/10.1111/neup.12205] [PMID: 25964057]
[12]
Hanna Al-Shaikh FS, Duara R, Crook JE, et al. Selective vulnerability of the nucleus basalis of meynert among neuropathologic subtypes of Alzheimer Disease. JAMA Neurol 2020; 77(2): 225-33.
[http://dx.doi.org/10.1001/jamaneurol.2019.3606] [PMID: 31657834]
[13]
Spina S, La Joie R, Petersen C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease. Brain 2021; 144(7): 2186-98.
[http://dx.doi.org/10.1093/brain/awab099] [PMID: 33693619]
[14]
Leverenz JB, Fishel MA, Peskind ER, et al. Lewy body pathology in familial Alzheimer disease: Evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006; 63(3): 370-6.
[http://dx.doi.org/10.1001/archneur.63.3.370] [PMID: 16533963]

Rights & Permissions Print Cite
Article Metrics
19
1
© 2024 Bentham Science Publishers | Privacy Policy